Bringing Together Innovators, Leading Investors and Major Healthcare Corporations
Now in its 32nd edition, MTI is Europe’s longest running healthcare investment and partnering forum, bringing together a fantastic range of breakthrough healthcare, life science and digital health firms seeking investment and partnerships with some of the most pro-active and ambitious investors in the sector.
Each event sees up to 40 technology companies pitching investment opportunities to an audience of 150 delegates including family offices, private wealth holders, VC’s, corporations, angel investors and many more. Central to the event is a forum programme that will address some of the major challenges and opportunities across healthcare, life science and digital health investment today.
Benefits of attending
The MTI events deliver the best ratio of investors to presenting companies, giving all attendees the maximum opportunity to meet, network and learn from the best in the business ensuring you meet the right investors and the right investment opportunities.
Do not miss this unique opportunity to meet with some of the most proactive entrepreneurs and investors in healthcare, learn how to fine-tune your strategy and ultimately maximise the potential for return from the sector.
The MTI forum programmes address the biggest topics in the industry today, from investment topics such as “Where is the money coming from?” and “What do family offices look for and how do they invest?” to wider challenges such as “How does healthcare economics playout in the real world?” and “How do you plan and execute a successful exit”.
The forum programmes have been developed in conjunction with the MTI Investor Advisory Board – a collection of the biggest investors in the sector with assets under management of over €50bn.
Our speaking faculties represent the truly global nature of the healthcare, life science and digital health sector with panellists drawn from leading investment organisations from Europe, North America, the Middle East and Asia.
Click here to download brochure
The core of our speaker faculty is made-up of some of the industry’s most active and ambitious investors joining on-stage discussion to give the latest insight into their investment strategy, the evolution of the sector, the most promising future opportunities and ultimately the opportunities they are looking for and to make investments in.
Leading the forum programme we are honoured to welcome back as chairman Dr Benoît Dubuis the Executive Director of Campus Biotech and the President of the world-renowned Inartis Foundation.
Benoît has over 30 years of international experience in Life Sciences, both in industry and in the academic world. After his engineering training, his doctorate from ETH Zurich (ETH Medal 1995) and an academic activity in Cambridge and Cranfield in England, he held various management positions in pharmaceutical companies (Chemap, Ciba-Geigy / Novartis, Lonza), before joining the École Polytechnique Fédérale de Lausanne (EPFL) where he founded the Faculty of Life Sciences.
Confirmed speakers will be updated at regular intervals as the events draws closer. If you are interested in speaking at the event please contact:
Peter Newton
+44(0)203 941 8019
peternewton@campdenwealth.com
Over the last 30 events we have showcased over 1000 venture-stage healthcare, life science and digital health companies to our unrivalled audience of investors. Representing all areas of the sector our presenting companies originate from over 37 countries and are at a range of different stages from pre-clinical to commercialisation.
For more information on how you can participate please email kevingrant@campdenwealth.com
A selection of the previously confirmed presenting companies at MTI events include:
Why attend as a delegate?
· Be the first to uncover the latest investment opportunities from our unrivalled range of Presenting Companies
· Meet over 40 investment opportunities over the duration of just 2 days
· Network with the leading investors and world-leading healthcare corporations
· Learn how to adapt your investment strategy for today’s climate
· Take away the tools to help your portfolio companies develop and grow to their full potential
Who are the delegates?
Every year MTI brings over 150 delegates together who are working at the cutting edge of healthcare, life science and digital health investment and partnering. Our investors represent some of the most pro-active and ambitious individuals from family offices, private wealth holders, VC’s, corporate VC’s, institutional investors, angels and managed funds to name but a few.
In order to ensure the best possible mix of investors and early-stage companies admission to all MTI events is strictly controlled and open to all qualifying companies and individuals. The organisers reserve the right to restrict admittance and delegate places.
How to register
Special packages and early booking price are now available, see the Registration Page for more information or contact:
Peter Newton
+44 (0)203 941 8019
Sponsors of the MTI events represent leading companies and organisations providing services to early to mid-stage life science companies, investors and major healthcare corporations.
Campus Biotech is a Swiss center of excellence in biotechnology and life sciences research focusing on three domains: Neuroscience & Neurotechnology, Digital Health and Global Health.
Founded in 2013 by a Consortium composed by the École polytechnique fédérale de Lausanne (EPFL), the University of Geneva (Unige), the Bertarelli Family and Hansjörg Wyss, the Campus functions like a giant incubator and focuses on pure science and its translation into real solutions and practical outcomes that have an impact on society and the world.
Campus Biotech was created to cross boundaries between disciplines and sectors, providing a unique ecosystem that brings academic, clinical, industrial and entrepreneurial actors together, to ensure projects to have access to the resources and skills that they need to push the frontiers of medical discoveries and to make breakthroughs.
Partners and scientists based at Campus Biotech become part of a diverse, dynamic culture of knowledge exchange.
For more information, please contact:
Fondation Inartis is a nonprofit whose purpose is to promote innovation, in particular in the tech and life science fields, and foster interactions between innovators, companies and research institutes.
Fondation Inartis runs different programmes such as the labs & coworking spaces UniverCité and Espace Creation, the startup accelerator MassChallenge Switzerland, the life science cluster of the Health Valley, and Inartis Network which is supported by the Swiss Confederation.
For more information, please contact:
11 Av. des Baumettes
1020 Renens
+41 21 697 11 21
fondation@inartis.ch
inartis.ch
State of Vaud - Office for Economic Affairs and Innovation (SPEI)
Canton of Vaud is one of the main centers of research and innovation in Switzerland, with the largest academic and technology campus in the country and several research institutes as well as industries of international reputation, particularly in life sciences, micro-nanotechnologies, ICT and cleantech.
In a few words :
A quarter of the 100 top Swiss startups are based in Vaud including 4 of the 10 top best ones in 2018 as well as about 2,000 high-tech companies
Vaud ranked 1st in fundraising for 4 consecutive years (2014-2017) in comparison to other Swiss cantonsas Vaud-based startups have raised up to CHF 1.2 bio over the past 5 years and CHF 267.5 mio in 2018
24 scaleups are based in Vaud and created 361 new jobs in 2018
There are 7 incubators and innovation parks suitable to develop your ideas and business, pooling local infrastructure and technical skills
About CHF +32 mio financial incentives have been distributed from the State of Vaud to startups/SMEs since 2012 to support their economic development.
Through its support to the MedTech Investing Europe Conference 2022, SPEI aims to showcase our region to all the international guests for what it really is: a direct connection with world-class academic and research institutes, a dense network of internationally oriented SMEs and innovative startups, and a vibrant location offering favorable conditions to expand your business.
The Office for Economic Affairs and Innovation (SPEI) supports companies that are exclusively based in Vaud, especially those involved in the sectors of advanced technology and industry. SPEI advises entrepreneurs and puts them in contact with organizations that are appropriate to their specific needs. SPEI can also provide direct financial support.
For more information, please contact:
State of Vaud – Department of Economy, Innovation and Sport (DEIS)
Office for Economic Affairs and Innovation (SPEI)
Rue Caroline 11
CH – 1014 Lausanne
+41 21 316 58 20
info.spei@vd.ch
invest-vaud.swiss
BioAlps is Western Switzerland's life sciences cluster.
The Association offers a dynamic network in #medtech, #biotech and #digitalhealth. With more than 1200 companies, 63 research and academic institutions, 67 public institutions and innovation parks, 5 000 students and researchers, 35 000 jobs, the region is the number one and most diversified life sciences ecosystem in Europe. Start-up companies and large multinationals are concentrated in a small, attractive geographic area with a great infrastructure.
BioAlps Association:
For more information, please contact:
BioAlps Association
Avenue de Sécheron 15
1202 Geneva
c/o Biopôle SA
Secteur Esplanade - Bâtiment Serine
Route de la Corniche 8
1066 Epalinges
Website: https://www.bioalps.org
Linked In: https://www.linkedin.com/company/3334168/admin/
Twitter: @BioAlps
Sectoral is specialized in managing equities globally in the healthcare sector. Founded in October 2000, we are SEC-registered as an investment advisor. 100% employee-owned, we have offices in Montreal, Geneva, and Hong Kong.
Sectoral Asset Management is an investment advisor exclusively focused on the global healthcare sector. The company manages public and private equity healthcare strategies for investors around the world. The company provides investment management services to a proprietary mutual fund, while serving certain clients with tailor made mandates and sub-advisory management agreements. Our clients include sovereign wealth funds, private banks and family offices. In addition, we have long-standing sub-advisory relationships with institutional investors in Europe and Asia. The company has a long track record in managing healthcare equities and one of the world’s longest track records in managing biotech equities.
Sectoral was founded in October 2000 by Jérôme Pfund, CFA and Michael Sjöström, CFA, based on the strong conviction that investing in innovative healthcare companies provides investors a superior risk-reward profile over the long term while driving lasting benefits for society through improved health and well-being.
As a signatory to the United Nations Principles for Responsible Investment (PRI), Sectoral Asset Management believes that responsible investing plays a role in achieving the best possible risk-adjusted returns. We aim to identify, monitor, and mitigate ESG risks and opportunities that are, or could become, material to the long-term performance of companies in our portfolios.
Mr. Pfund and Mr. Sjöström enjoy a longstanding working relationship, which began in 1993.
Sectoral is present on three continents to better serve its clients and investors. Sectoral group entities are located at:
Sectoral is registered with the Securities and Exchange Commission (SEC) in the U.S, the Autorité des Marchés Financiers (AMF) in Quebec, Canada, and the Securities and Futures Commission (SFC) in Hong Kong.
For more information, please contact:
Sectoral Asset Management Inc.
7 rue du Mont Blanc
1201 Geneva
Switzerland
Tel: +41 22 316 66 33
Web: www.sectoral.com
To enquire about sponsorship opportunities at upcoming MTI events, please contact Kevin Grant on kevingrant@campdenwealth.com
The MedTech Investing Europe Forum will once again be run as an integrated event, bringing together an unrivalled audience of investors, venture-stage companies and experts from across healthcare, life sciences and digital health both in-person in Lausanne on 12-13 July and then virtually on 21 July.
Having adapted and evolved under the disruption of recent years, we have leveraged the virtual event format allowing all the venture-stage presenting companies and investors who participate in-person, as well as those who participate exclusively at the virtual event, to reach a broader, more global audience.
As an attendee you will benefit from everything an MTI event would normally offer from the all-important Presenting Company streams bringing the latest technologies and investment opportunities, to in-depth insight from our forum chairman, as well as improved and extended networking opportunities and One-To-One meetings.
Attendees to the in-person forum will automatically be registered for the virtual event, all other attendees are required to pre-register and will receive full details, access links and schedule in advance of the event.
To register your interest please contact:
peternewton@campdenwealth.com or call +44 (0) 20 3941 8019
The Canton of Vaud
The canton of Vaud is one of the main centres of research and innovation in Switzerland, with the biggest university campus in the country and several public and private research institutions. The canton is also at the centre of supra-regional technical cluster, with companies located in the canton of Vaud able to benefit from close links between the research centres and industry.
Hotel Royal Savoy Lausanne
Set in the heart of Lausanne, originally built in 1909 and painstakingly restored to its pristine beauty this The Royal Savoy Hotel is now a landmark representing luxury and style complemented by an elegant yet contemporary design. Located adjacent to the majestic Lake Geneva and one hour from Geneva airport this hotel is ideal for visitors who appreciate culture, heritage and history, whilst enjoying up to date modern facilities of a first class hotel.
Avenue d'Ouchy 40 (Entry of the hotel: Avenue de Cour)
1006 Lausanne
Telephone: +41 21 614 88 88
Telefax: +41 21 614 88 78
E-mail: info@royalsavoy.ch
http://www.royalsavoy.ch/en
ACCOMMODATION
We are working closely with Hotel Royal Savoy Lausanne and all our participants will be able to benefit from preferential rates for accommodation during the event. As soon as participants confirm their registration, booking details will be provided.
If you require any assistance please contact Peter Newton at peternewton@campdenwealth.com or +44(0)203 941 8019.
Additional Hotels
There are numerous hotels close by ranging from 3* to 5*. If you wish to stay off-site, we would suggest any of the following:
Hotel in Lausanne |
Cost |
Distance |
Carlton Lausanne Boutique Hotel |
Approx. CHF 210 p/night |
1 min walk from venue |
Agora Swiss Night by Fassbind |
Approx. CHF 180 p /night |
7 min walk from venue |
Alpha-Palmiers Hotel by Fassbind |
Approx. CHF 170 p /night |
12 min walk from venue |
Hotel Victoria |
Approx. CHF 210 p /night |
11 min walk from venue |
ibis Styles Lausanne Center Mad House |
Approx. CHF 110 p /night |
17 min walk from venue |
Prices taken from April 2022. Prices may change closer to time of event.
DELIVERIES
If you have deliveries, please send your materials to:
Juliette Courtin
ROYAL SAVOY HOTEL & SPA
Avenue d’Ouchy 40
1006 Lausanne – Switzerland
(Campden Wealth Event – 12 & 13 July)
Nova North, 6th Floor, 11 Bressenden Place, London, SW1E 5BY, United Kingdom